Navin Fluorine International reported a strong Q2FY27 with revenue up 57% and PAT rising 81% year-on-year. Driven by growth in its High Performance Products and CDMO segments, the company also extended a major supply agreement, prompting Axis Securities to hike its price target to Rs 9,650.
Navin Fluorine Q2 Profit Jumps 81% to Rs 269 Cr
Revenue grew 57% year-on-year to Rs 1,191 Cr, beating analyst expectations.
Reader Takeaway: Strong segment growth and a $180 million contract extension drive optimism, though capex execution remains the key monitorable.
What just happened
Navin Fluorine International posted a robust Q2FY27, significantly outpacing market estimates. The company reported a net profit of Rs 269 Cr, marking an 81% jump compared to the same quarter last year. Revenue saw a healthy 57% growth to Rs 1,191 Cr, supported by strong volume growth across its core business units.
Why this matters
The growth was broad-based, with the High Performance Products (HPP) segment contributing Rs 604 Cr (up 49% YoY). The CDMO segment, a high-growth vertical, saw an impressive 78% revenue increase to Rs 239 Cr. Furthermore, the extension of a supply agreement with Solstice Advanced Materials until 2032 provides long-term revenue visibility, adding roughly $180 million to the company’s potential earnings.
Capacity Expansion Updates
Management confirmed that critical growth projects are moving forward. The Chemours Liquid Cooling project is expected to commission in Q3FY27. Additionally, the cGMP4 Phase II expansion is slated for completion by the end of Q4FY27, aiming for an asset turnover of 3x. The 15,000 MTPA R32 expansion is also approaching commissioning, which is expected to support future volume growth.
Risks to watch
While the outlook is positive, investors should be mindful of potential global recessionary pressures that could impact demand. Operational risks, including fluctuations in raw material prices and potential delays in the commercialization of upcoming plants, remain factors that could impact margins and growth timelines.
Context metrics (Q2FY27)
- Net Sales: Rs 1,191 Cr (57% YoY growth)
- EBITDA: Rs 407 Cr (66% YoY growth)
- EPS: Rs 52.6 (81% YoY growth)
What to track next
Watch for the official commissioning dates of the Chemours Liquid Cooling project and the cGMP4 facility, as these will be primary drivers for future performance. Global chemical demand trends should also be monitored to ensure they align with management’s growth projections.